OSAM
DMAC icon

O'Shaughnessy Asset Management’s DiaMedica Therapeutics DMAC Stock Holding History

O'Shaughnessy Asset Management’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-45
Closed – – 2751
2021
Q2 		$0 Sell
45
-20
-31% -$164 ﹤0.01% 2597
2021
Q1 		$1K Buy
+65
New +$607 ﹤0.01% 2160

Other funds holding DMAC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
JAMONY
Jacob Asset Management of New York Hermosa Beach, California $70.9M AUM 14.28% 1-Year Est. Return
MHP
Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return
CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

O'Shaughnessy Asset Management's DMAC Position: Q3 2021 in Review

O'Shaughnessy Asset Management sold out of DiaMedica Therapeutics (DMAC) in Q3 2021, closing a stake of 45 shares.

O'Shaughnessy Asset Management first reported a position in DMAC in Q1 2021 and held it in 2 quarters. The position peaked at $1K in Q1 2021. 34 funds tracked by Wall St. Rank hold DMAC as of Q3 2021.

  • O'Shaughnessy Asset Management reported no remaining DiaMedica Therapeutics position as of Q3 2021 after selling out during the quarter.
  • O'Shaughnessy Asset Management sold 45 DiaMedica Therapeutics shares in Q3 2021.
  • O'Shaughnessy Asset Management first reported a position in DiaMedica Therapeutics in Q1 2021 and held it in 2 quarters.
  • O'Shaughnessy Asset Management's DiaMedica Therapeutics position peaked at $1K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q3 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q3 2021, filed 10 Nov 2021.